Can circulating tumor DNA (ctDNA) detect cancer recurrence in patients being treated for esophageal cancer or gastroesophageal (GE) cancer earlier than traditional clinical or radiographic methods? Investigators presenting new research at the
Detectable ctDNA Potential Predictor of Gastroesophageal, Esophageal Cancer Recurrence
